Lv61
1730 积分 2024-08-22 加入
Process Validation in Manufacturing of Biopharmaceuticals
5天前
已关闭
Abstract LB032: Preclinical evaluation of GPC3 targeting antibody-TCR T cells in HCC models with tumor rechallenging
6天前
已关闭
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
11天前
已完结
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
1个月前
已完结
TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens
1个月前
已完结
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
1个月前
已完结
International approvals of cilta-cel: a lens on CAR T cell regulation
2个月前
已完结
Exclusive: These universities have the most retracted scientific articles
2个月前
已完结
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
2个月前
已完结
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53
2个月前
已完结
皖公网安备34019202002308
